tiprankstipranks

Anastasios Gianakakos Insider Profile

4 Followers
Anastasios Gianakakos, SVP, COR & Business Dev at Map Pharmaceuticals, holds 0.00 shares in Map Pharmaceuticals (Ticker: MAPP), holds 624.79K shares in MyoKardia (Ticker: MYOK). Most recently, Anastasios Gianakakos ― shares of Map Pharmaceuticals on ― for an estimated value of ―.
tipranks
Anastasios Gianakakos

Anastasios Gianakakos
Map Pharmaceuticals (MAPP)
SVP, COR & Business Dev

Ranked #5,602 out of 78,624 Corporate Insiders

Profitable Transactions

80%
4 out of 5 Profitable Transactions

Average Return

+55.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Anastasios Gianakakos does not currently own shares as a corporate insider.
A breakdown of Anastasios Gianakakos's holdings

Insider Roles

Anastasios Gianakakos does not currently hold a role as a corporate insider.
Roles that Anastasios Gianakakos holds in companies

Most Profitable Insider Trade

Stock:
MyoKardia
(MYOK)
Rating:Informative Buy
Date:May 04, 2020 - May 04, 2021
Return:+280.60%
The most profitable trade made by Anastasios Gianakakos

Anastasios Gianakakos's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
MAPP
Map Pharmaceuticals
MYOK
MyoKardia
Jul 07, 2020
Uninformative Sell
469.89K
$140.52M
List of latest transactions for each holding click on a transaction to see Anastasios Gianakakos's performance on stock

Anastasios Gianakakos insider profile FAQ

What is the percentage of profitable transactions made by Anastasios Gianakakos?
The percentage of profitable transactions made by Anastasios Gianakakos is 80%.
    What is the average return per transaction made by Anastasios Gianakakos?
    The average return per transaction made by Anastasios Gianakakos is 55.00%.
      What stocks does Anastasios Gianakakos hold?
      Anastasios Gianakakos holds: MAPP, MYOK stocks.
        What was Anastasios Gianakakos’s latest transaction?
        Anastasios Gianakakos latest transaction was an Uninformative Buy of ―.
          What was Anastasios Gianakakos's most profitable transaction?
          Anastasios Gianakakos’s most profitable transaction was an Informative Buy of MYOK stock on May 4, 2020. The return on the trade was 280.60%.
            What is Anastasios Gianakakos's role in Map Pharmaceuticals?
            Anastasios Gianakakos's role in Map Pharmaceuticals is SVP, COR & Business Dev.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.